ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted January 12, 2016

Over $400,000 Worth of Kratom Supplements Seized by U.S. Marshals

On January 6, 2016, U.S. Marshals seized nearly 90,000 bottles of dietary supplements labeled as containing kratom (brand name RelaKzpro) valued at over $400,000, from Dordoniz Natural Products LLC in South Beloit, Illinois. The action was taken at the request of the FDA.

Kratom (Mitragyna speciosa), also called mitragynine extract, biak-biak, cratom, gratom, ithang, kakuam, katawn, kedemba, ketum, krathom, krton, mambog, madat, Maeng da leaf, nauclea, Nauclea speciosa, or thang is a tree native to Southeast Asia. Supplements containing kratom typically contain powdered leaves or extract sold in powder, capsules or liquid, and are promoted for pain relief or energy.

Kratom has pharmacological effects similar to morphine and other opiates. Consumption has been associated with respiratory depression, nervousness, agitation, aggression, sleeplessness, hallucinations, delusions, tremors, loss of libido, constipation, skin hyperpigmentation, nausea, vomiting, and severe withdrawal symptoms.

"We have identified kratom as a botanical substance that poses a risk to public health and has the potential for abuse," stated Melinda Plaisier, the FDA's associate commissioner for regulatory affairs.

In 2014, the FDA issued an import alert in 2014 on all products containing kratom and in March 2014, a number of products containing this ingredient were recalled.

See Related Warnings:

U.S. Marshals Seize $5 Million Worth of Kratom

Products Containing Kratom Recalled Following FDA Import Alert

$2 Million In Weight Loss and "Fat-Burning" Supplements Seized

FDA Seizes Weight Loss Supplements Containing Undeclared Drug

FDA Requests Seizure of More Supplements Containing Ephedrine Alkaloids

To read the FDA's press release, use the link below.